课题基金 / 基金详情

Development of Second Messenger, Trafficking, and Functional Assays for GPR119

Development of Second Messenger, Trafficking, and Functional Assays for GPR119
GPR119 第二信使的开发、贩运和功能分析
批准号:
7866783
负责人:
Patricia Helen McDonald
金额:
$48.63万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-05 至 2013-03-31

项目摘要

项目成果

Patricia Helen McDonald的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The G protein coupled receptor GPR119 is a recently deophanized receptor that has emerged as an attractive target for the treatment of obesity and Type 2 Diabetes Mellitus. Recent studies in animal models have demonstrated that activation of GPR119 improves glucose homeostasis while positively modulating both food intake and weight gain. It is expressed predominantly in the pancreas and gut of humans and rats and in rodent brain. Activation of GPR119 promotes secretion of the incretin GLP1 from intestinal L cells and insulin from pancreatic beta cells, both key components in regulating glucose homeostasis. Small molecule modulators of GPR119 have recently been reported however, these molecules differ with respect to their signaling properties and insulin secretion from the endogenous ligand Olethylethanolamide (OEA), rendering them unsuitable probes for the interrogation of GPR119 biology and function. The emphasis of this application is on developing innovative and novel assays for GPR119 that are HTS compatible, secondary screening assays to triage artifacts, counterscreens to assess selectivity of compounds versus two structurally related GPCRs and functional assays to elucidate pharmacology of compounds in physiologically relevant cell types to assess in vitro efficacy for promoting incretin and insulin secretion. These assays are designed to be the cornerstone for the discovery of novel small molecule probes to be used in the exploration of GPR119 biology and function. PUBLIC HEALTH RELEVANCE: The GPR119 receptor is expressed in the pancreas and gastrointestinal tract and has recently emerged as an attractive target for the treatment of obesity and Type 2 Diabetes Mellitus. This proposal seeks to develop a series of novel high throughput compatible cell-based functional assay to identify GPR119 selective ligands that can be used as molecular probes to interrogate GPR119 receptor function in normal physiological processes and disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A High Content Screening Platform for High Throughput, High Content Imaging and Analysis
Assay Development for Substrate and Phosphorylation State Specific JNK Inhibitors
  • 批准号:
    8910762
  • 项目类别:
  • 资助金额:
    $36.48万
  • 财政年份:
    2013
  • 负责人:
    Patricia Helen McDonald
  • 依托单位:
Development of Chemical Probes to Investigate the Role of NTSR1 in CNS Disorders
  • 批准号:
    8082595
  • 项目类别:
  • 资助金额:
    $42.4万
  • 财政年份:
    2010
  • 负责人:
    Patricia Helen McDonald
  • 依托单位:
Development of Second Messenger, Trafficking, and Functional Assays for GPR119
  • 批准号:
    8056100
  • 项目类别:
  • 资助金额:
    $41.12万
  • 财政年份:
    2010
  • 负责人:
    Patricia Helen McDonald
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: